TrialScientific reports2018

Metformin add-on continuous subcutaneous insulin infusion on precise insulin doses in patients with type 2 diabetes.

Feng-Fei Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.